FDA Recalls Antidepressants That Are "Possibly" Cancerous

FDA Recalls Antidepressants That Are "Possibly" Cancerous

(Washington, DC) -- Over 230-thousand bottles of antidepressants are being recalled over a possible cancerous chemical. Duloxetine was recently classified by the FDA as a Class Two risk, which is the agency's second most severe level, because it could have "temporary or medically reversible adverse health consequences." The FDA says over 230-thousand bottles of the drug were sold by a New Jersey pharmaceutical company, and that the capsules contain the "presence" of nitrosamine, which "may increase the risk of cancer if people are exposed to them above acceptable levels and over long periods of time."